Pages not connected to items

Jump to navigation Jump to search

This page lists pages with no connected data item (in namespaces that support connected items). The list is sorted by descending page ID, so that newer pages are listed first.

 

Showing below up to 50 results in range #6,351 to #6,400.

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

  1. Darash-Yahana M, et al. FASEB J. (2004) cited as Ref 675 in DOI: 10.1038/s41392-020-0110-5 (Q9938)
  2. Ugolkov AV, et al. Prostate (2011) cited as Ref 674 in DOI: 10.1038/s41392-020-0110-5 (Q9937)
  3. Patrawala L, et al. Oncogene (2006) cited as Ref 673 in DOI: 10.1038/s41392-020-0110-5 (Q9936)
  4. Kerr BA, et al. Oncotarget (2015) cited as Ref 672 in DOI: 10.1038/s41392-020-0110-5 (Q9935)
  5. Deng Zhenling, et al. BMC Immunology (2015) cited as Ref 671 in DOI: 10.1038/s41392-020-0110-5 (Q9934)
  6. Vassilopoulos A, et al. Oncogene (2014) cited as Ref 670 in DOI: 10.1038/s41392-020-0110-5 (Q9933)
  7. Baumann P, et al. Cancer Res. (2005) cited as Ref 669 in DOI: 10.1038/s41392-020-0110-5 (Q9932)
  8. Yin AH, et al. Blood (1997) cited as Ref 668 in DOI: 10.1038/s41392-020-0110-5 (Q9931)
  9. Kumar A, et al. Tumour Biol. (2016) cited as Ref 667 in DOI: 10.1038/s41392-020-0110-5 (Q9930)
  10. Azevedo R, et al. Clin. Proteom. (2018) cited as Ref 666 in DOI: 10.1038/s41392-020-0110-5 (Q9929)
  11. Moreb J, et al. Cancer Gene Ther. (1996) cited as Ref 665 in DOI: 10.1038/s41392-020-0110-5 (Q9928)
  12. Wright MH, et al. Breast Cancer Res. (2008) cited as Ref 664 in DOI: 10.1038/s41392-020-0110-5 (Q9927)
  13. Fillmore CM, et al. Breast Cancer Res. (2008) cited as Ref 663 in DOI: 10.1038/s41392-020-0110-5 (Q9926)
  14. Ricardo S, et al. J. Clin. Pathol. (2011) cited as Ref 662 in DOI: 10.1038/s41392-020-0110-5 (Q9925)
  15. Liu TJ, et al. Oncogene (2013) cited as Ref 661 in DOI: 10.1038/s41392-020-0110-5 (Q9924)
  16. Lu HH, et al. Nat. Cell Biol. (2014) cited as Ref 660 in DOI: 10.1038/s41392-020-0110-5 (Q9923)
  17. Pece S, et al. Cell (2010) cited as Ref 659 in DOI: 10.1038/s41392-020-0110-5 (Q9922)
  18. Shackleton M, et al. Nature (2006) cited as Ref 658 in DOI: 10.1038/s41392-020-0110-5 (Q9921)
  19. Moselhy J, et al. Anticancer Res. (2015) cited as Ref 657 in DOI: 10.1038/s41392-020-0110-5 (Q9920)
  20. Du F-Y, et al. World J. Stem Cells (2019) cited as Ref 656 in DOI: 10.1038/s41392-020-0110-5 (Q9919)
  21. Sancho P, et al. Br. J. Cancer (2016) cited as Ref 655 in DOI: 10.1038/s41392-020-0110-5 (Q9918)
  22. Wainwright EN, et al. Trends Cancer (2017) cited as Ref 654 in DOI: 10.1038/s41392-020-0110-5 (Q9917)
  23. Jiang Q, et al. Nat. Rev. Cancer (2017) cited as Ref 653 in DOI: 10.1038/s41392-020-0110-5 (Q9916)
  24. Takeishi S, et al. Cancer Sci. (2016) cited as Ref 652 in DOI: 10.1038/s41392-020-0110-5 (Q9915)
  25. Plaks V, et al. Cell Stem Cell (2015) cited as Ref 651 in DOI: 10.1038/s41392-020-0110-5 (Q9914)
  26. Shultz LD, et al. Nat. Rev. Immunol. (2012) cited as Ref 650 in DOI: 10.1038/s41392-020-0110-5 (Q9913)
  27. Bao B, et al. Current protocols in pharmacology Chapter 14:Unit14.25 (2013) cited as Ref 649 in DOI: 10.1038/s41392-020-0110-5 (Q9912)
  28. Liu B, et al. Am. J. Cancer Res. (2019) cited as Ref 648 in DOI: 10.1038/s41392-020-0110-5 (Q9911)
  29. Chang L, et al. Oncotarget (2016) cited as Ref 647 in DOI: 10.1038/s41392-020-0110-5 (Q9910)
  30. Zhao J, et al. Pharmacol. Ther. (2016) cited as Ref 646 in DOI: 10.1038/s41392-020-0110-5 (Q9909)
  31. Prieto-Vila M, et al. Int. J. Mol. Sci. (2017) cited as Ref 645 in DOI: 10.1038/s41392-020-0110-5 (Q9908)
  32. Rich JN, et al. Medicine (2016) cited as Ref 644 in DOI: 10.1038/s41392-020-0110-5 (Q9907)
  33. Nandy SB, et al. Prog. Mol. Biol. Transl. Sci. (2017) cited as Ref 643 in DOI: 10.1038/s41392-020-0110-5 (Q9906)
  34. Hodi FS, et al. N. Engl. J. Med. (2010) cited as Ref 642 in DOI: 10.1038/s41392-020-0110-5 (Q9905)
  35. Sullivan RJ, et al. Nat. Med. (2019) cited as Ref 641 in DOI: 10.1038/s41392-020-0110-5 (Q9904)
  36. Fujiwara Y, et al. Cancer Sci. (2019) cited as Ref 640 in DOI: 10.1038/s41392-020-0110-5 (Q9903)
  37. Motzer RJ, et al. N. Engl. J. Med. (2019) cited as Ref 639 in DOI: 10.1038/s41392-020-0110-5 (Q9902)
  38. Migden MR, et al. N. Engl. J. Med. (2018) cited as Ref 638 in DOI: 10.1038/s41392-020-0110-5 (Q9901)
  39. Cortese I, et al. N. Engl. J. Med. (2019) cited as Ref 637 in DOI: 10.1038/s41392-020-0110-5 (Q9900)
  40. Meindl-Beinker NM, et al. BMC Cancer (2019) cited as Ref 636 in DOI: 10.1038/s41392-020-0110-5 (Q9899)
  41. Sakamuri D, et al. Mol. Cancer Ther. (2018) cited as Ref 635 in DOI: 10.1038/s41392-020-0110-5 (Q9898)
  42. Salgia R, et al. Lung Cancer (2017) cited as Ref 634 in DOI: 10.1038/s41392-020-0110-5 (Q9897)
  43. Hainsworth JD, et al. Target Oncol. (2016) cited as Ref 633 in DOI: 10.1038/s41392-020-0110-5 (Q9896)
  44. Galsky MD, et al. Clin. Cancer Res. (2014) cited as Ref 632 in DOI: 10.1038/s41392-020-0110-5 (Q9895)
  45. Cooper TM, et al. Pediatr. Blood Cancer (2017) cited as Ref 631 in DOI: 10.1038/s41392-020-0110-5 (Q9894)
  46. Uy GL, et al. Blood (2012) cited as Ref 630 in DOI: 10.1038/s41392-020-0110-5 (Q9893)
  47. Cashen A, et al. Biol. Blood Marrow Transplant. (2008) cited as Ref 629 in DOI: 10.1038/s41392-020-0110-5 (Q9892)
  48. Saygin C, et al. Cell Stem Cell (2019) cited as Ref 628 in DOI: 10.1038/s41392-020-0110-5 (Q9891)
  49. Konopleva M, et al. Cancer Discov. (2016) cited as Ref 627 in DOI: 10.1038/s41392-020-0110-5 (Q9890)
  50. Cortes JE, et al. J. Clin. Oncol. (2015) cited as Ref 626 in DOI: 10.1038/s41392-020-0110-5 (Q9889)

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)